Join
Live feed
·
INSIDERFilingvia Quantisnow
Eagle Pharmaceuticals Inc. logo

Tarriff Scott sold $300,026 worth of shares (20,245 units at $14.82), decreasing direct ownership by 3% to 567,066 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EGRX· Eagle Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EGRX (Eagle Pharmaceuticals Inc.) and more on Quantisnow.